EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.239 | 3alpha(17beta)-hydroxysteroid dehydrogenase (NAD+) |
leukemia cell |
- |
739864 |
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
leukemia cell |
- |
761332 |
1.1.1.41 | isocitrate dehydrogenase (NAD+) |
leukemia cell |
acute |
712180 |
1.1.1.42 | isocitrate dehydrogenase (NADP+) |
leukemia cell |
acute |
712180 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
leukemia cell |
basophil leucemia cell line S1 wild-type cell line and (RBL)2H3 cell line overexpressing mitochondrial phospholipid hydroperoxide glutathione peroxidase |
394883 |
1.13.11.31 | arachidonate 12-lipoxygenase |
leukemia cell |
basophilic |
395401, 395402, 395414, 395416 |
1.13.11.34 | arachidonate 5-lipoxygenase |
leukemia cell |
- |
439437, 439444, 439449, 439450, 439460, 439461, 439462, 439467, 439471, 728431 |
1.13.11.34 | arachidonate 5-lipoxygenase |
leukemia cell |
unstimulated basophilic leukemia cells |
439470 |
1.14.11.27 | [histone H3]-dimethyl-L-lysine36 demethylase |
leukemia cell |
high expression level of KDM2b/JHDM1b |
724651 |
1.14.11.65 | [histone H3]-dimethyl-L-lysine9 demethylase |
leukemia cell |
- |
755188 |
1.14.99.66 | [histone H3]-N6,N6-dimethyl-L-lysine4 FAD-dependent demethylase |
leukemia cell |
- |
755188 |
1.6.3.1 | NAD(P)H oxidase (H2O2-forming) |
leukemia cell |
- |
712075 |
1.8.1.7 | glutathione-disulfide reductase |
leukemia cell |
- |
671910 |
2.1.2.2 | phosphoribosylglycinamide formyltransferase 1 |
leukemia cell |
- |
735672 |
2.1.2.3 | phosphoribosylaminoimidazolecarboxamide formyltransferase |
leukemia cell |
- |
719415 |
2.3.1.23 | 1-acylglycerophosphocholine O-acyltransferase |
leukemia cell |
- |
736546 |
2.4.1.144 | beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
leukemia cell |
- |
638223 |
2.4.1.144 | beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
leukemia cell |
from patients with chronic lymphocytic leukemia CLL or acute lymphoblastic leukemia ALL |
638218 |
2.4.1.80 | ceramide glucosyltransferase |
leukemia cell |
it is shown that overexpression of the GCS gene is associated with multidrug resistance of leukemia cells |
693944 |
2.4.2.14 | amidophosphoribosyltransferase |
leukemia cell |
L1210 leukemia cells |
489768 |
2.4.2.19 | nicotinate-nucleotide diphosphorylase (carboxylating) |
leukemia cell |
- |
758726 |
2.4.2.3 | uridine phosphorylase |
leukemia cell |
- |
638512 |
2.4.3.8 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase |
leukemia cell |
- |
764812 |
2.7.1.105 | 6-phosphofructo-2-kinase |
leukemia cell |
- |
739045 |
2.7.1.105 | 6-phosphofructo-2-kinase |
leukemia cell |
constitutively expressed in |
694113 |
2.7.1.105 | 6-phosphofructo-2-kinase |
leukemia cell |
PFKFB3 is constitutively expressed |
673215 |
2.7.1.113 | deoxyguanosine kinase |
leukemia cell |
- |
671919 |
2.7.1.137 | phosphatidylinositol 3-kinase |
leukemia cell |
- |
708040 |
2.7.1.147 | ADP-specific glucose/glucosamine kinase |
leukemia cell |
- |
723169 |
2.7.1.153 | phosphatidylinositol-4,5-bisphosphate 3-kinase |
leukemia cell |
primary human acute myeloid leukemia (AML) cells |
739390 |
2.7.1.20 | adenosine kinase |
leukemia cell |
L1210, implanted in mice |
641093 |
2.7.1.67 | 1-phosphatidylinositol 4-kinase |
leukemia cell |
- |
673995 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
- |
674748, 721556 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
cell line MOLT-4 |
641941, 641942, 641946, 641967 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
from acute myeloid leukemia (AML) patients |
641938, 641948 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
from peripheral blood |
641938 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
from spleen |
641937, 641939, 641943, 641963, 641965 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
L1210 |
641929 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
leukemic T-lymphoblasts |
641940, 641941, 641942, 641943, 641944, 641946 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
lymphocytes |
641945 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
ML-1 cells |
641938 |
2.7.1.74 | deoxycytidine kinase |
leukemia cell |
various spontaneous leukemic cells |
641966 |
2.7.1.91 | sphingosine kinase |
leukemia cell |
- |
671356, 704087 |
2.7.10.1 | receptor protein-tyrosine kinase |
leukemia cell |
from peripheral bloods or bone marrows |
691595 |
2.7.10.1 | receptor protein-tyrosine kinase |
leukemia cell |
preferentially expressed in leukemias (10 out of 18 cases) with no cell lineage specificity, but none of 17 nonleukemic neoplasms expressed hltk gene |
490375 |
2.7.10.2 | non-specific protein-tyrosine kinase |
leukemia cell |
basophilic leukemia cell line KU812 |
490455 |
2.7.10.2 | non-specific protein-tyrosine kinase |
leukemia cell |
K-562 leukemia cells |
490320 |
2.7.10.2 | non-specific protein-tyrosine kinase |
leukemia cell |
K562 human leukemia cell line |
490423 |
2.7.11.1 | non-specific serine/threonine protein kinase |
leukemia cell |
primary human acute myeloid leukemia (AML) cells |
739390 |
2.7.11.12 | cGMP-dependent protein kinase |
leukemia cell |
- |
675209 |
2.7.11.15 | beta-adrenergic-receptor kinase |
leukemia cell |
myeloid and lymphoid leukemia cell lines, high expression of beta-ARK 1 |
490989 |
2.7.11.2 | [pyruvate dehydrogenase (acetyl-transferring)] kinase |
leukemia cell |
- |
723186 |
2.7.11.24 | mitogen-activated protein kinase |
leukemia cell |
- |
679691 |
2.7.4.14 | UMP/CMP kinase |
leukemia cell |
high expression |
693063 |
2.7.7.31 | DNA nucleotidylexotransferase |
leukemia cell |
- |
643220, 643234, 660645 |
2.7.7.31 | DNA nucleotidylexotransferase |
leukemia cell |
molt-4 cells and leukocytes of patient with acute lymphoblastic leukemia |
643209 |
2.7.7.31 | DNA nucleotidylexotransferase |
leukemia cell |
more than 90% of leukemic cells in acute lymphocytic leukemia and approximately 30% of leukemic cells in the chronic myelogenous leukemia crisis show elevated TDP activity |
662919 |
2.7.7.31 | DNA nucleotidylexotransferase |
leukemia cell |
multiple patterns of isoforms are expressed in each tumor |
660645 |
3.1.1.7 | acetylcholinesterase |
leukemia cell |
from acute lymphoblastic leukemia patient blood |
691870 |
3.1.22.1 | deoxyribonuclease II |
leukemia cell |
- |
134310 |
3.1.4.12 | sphingomyelin phosphodiesterase |
leukemia cell |
- |
691456 |
3.2.1.143 | poly(ADP-ribose) glycohydrolase |
leukemia cell |
- |
754952 |
3.2.1.31 | beta-glucuronidase |
leukemia cell |
basophilic tumor |
26855 |
3.2.1.31 | beta-glucuronidase |
leukemia cell |
chronic myelogenous |
654921 |
3.4.22.1 | cathepsin B |
leukemia cell |
chronic myelogenous |
709771 |
3.4.22.26 | cancer procoagulant |
leukemia cell |
- |
651435 |
3.4.22.40 | bleomycin hydrolase |
leukemia cell |
high expression level |
668771 |
3.4.22.56 | caspase-3 |
leukemia cell |
chronic lymphocytic |
698346 |
3.4.22.59 | caspase-6 |
leukemia cell |
THP-1 human monocytic cell culture |
669243 |
3.4.22.61 | caspase-8 |
leukemia cell |
- |
700899 |
3.4.22.63 | caspase-10 |
leukemia cell |
- |
666516, 710208 |
3.5.3.6 | arginine deiminase |
leukemia cell |
lymphatic |
685929 |
3.6.5.1 | heterotrimeric G-protein GTPase |
leukemia cell |
- |
644110 |
4.2.1.11 | phosphopyruvate hydratase |
leukemia cell |
ENOA is upregulated |
714970 |
4.6.1.19 | ribonuclease T2 |
leukemia cell |
- |
729281 |
6.2.1.45 | E1 ubiquitin-activating enzyme |
leukemia cell |
- |
707854 |
6.2.1.64 | E1 NEDD8-activating enzyme |
leukemia cell |
- |
758191 |
6.3.1.1 | aspartate-ammonia ligase |
leukemia cell |
mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients, method development and optimization, overview |
693874 |
6.3.1.4 | aspartate-ammonia ligase (ADP-forming) |
leukemia cell |
mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients, method development and optimization, overview |
693874 |
6.3.2.17 | tetrahydrofolate synthase |
leukemia cell |
- |
745104 |
6.3.4.2 | CTP synthase (glutamine hydrolysing) |
leukemia cell |
significantly higher activity is detected in leukaemic cells of children suffering from acute lymphocytic leukemia than in lymphocytes of healthy controls |
648967 |
6.3.5.4 | asparagine synthase (glutamine-hydrolysing) |
leukemia cell |
- |
671350 |